Michael Lawlor, MD PhD
Affiliations: | Childrens Hospital Boston, Harvard Medical School, Boston, MA, United States |
Website:
http://www.linkedin.com/pub/mike-lawlor/a/4a3/a25Google:
"Michael Lawlor"Mean distance: 17.42 (cluster 24) | S | N | B | C | P |
Parents
Sign in to add mentor| E. Tessa Hedley-Whyte | post-doc | 2006-2008 | Harvard Medical School and Masssachusetts General Hospital |
| Alan H. Beggs | post-doc | 2007-2011 | Harvard Medical School (GenetiTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Karimi E, van der Borgh M, Lindqvist J, et al. (2023) Characterization of mutations in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects. Biorxiv : the Preprint Server For Biology |
| Lawlor MW, Schoser B, Margeta M, et al. (2023) Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial. Ebiomedicine. 99: 104894 |
| Shieh PB, Kuntz NL, Dowling JJ, et al. (2023) Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial. The Lancet. Neurology. 22: 1125-1139 |
| Slick RA, Tinklenberg JA, Sutton J, et al. (2023) Aberrations in Energetic Metabolism and Stress-Related Pathways Contribute to Pathophysiology in the Neb Conditional Knockout Mouse Model of Nemaline Myopathy. The American Journal of Pathology |
| Tinklenberg JA, Slick RA, Sutton J, et al. (2023) Different Mouse Models of Nemaline Myopathy Harboring Acta1 Mutations Display Differing Abnormalities Related to Mitochondrial Biology. The American Journal of Pathology |
| Gartz M, Haberman M, Sutton J, et al. (2023) ACTA1 H40Y mutant iPSC-derived skeletal myocytes display mitochondrial defects in an in vitro model of nemaline myopathy. Experimental Cell Research. 424: 113507 |
| Birch SM, Lawlor MW, Conlon TJ, et al. (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Science Translational Medicine. 15: eabo1815 |
| Boehler JF, Brown KJ, Beatka M, et al. (2022) Clinical potential of microdystrophin as a surrogate endpoint. Neuromuscular Disorders : Nmd |
| Dowling JJ, Müller-Felber W, Smith BK, et al. (2022) INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy. Journal of Neuromuscular Diseases |
| Gartz M, Haberman M, Prom MJ, et al. (2022) A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in Mice. Journal of Cardiovascular Pharmacology and Therapeutics. 27: 10742484221088655 |